Almazroo, Omar Abdulhameed
Shaik, Imam H
Hughes, Christopher B
Humar, Abhinav
Venkataramanan, Raman
Article History
Received: 10 June 2022
Accepted: 27 August 2022
First Online: 7 September 2022
Declarations
:
: There are no conflicts of interest to disclose.
: The study was partially funded by a grant from United Therapeutics Corporation and United Therapeutics Corporation provided Treprostinil (intervention drug).Almazroo OA currently works at Saudi Food and Drug Authority, Riyadh, Saudi Arabia.